GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (STU:1KJ) » Definitions » Total Liabilities

10x Genomics (STU:1KJ) Total Liabilities : €187.8 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics Total Liabilities?

10x Genomics's Total Liabilities for the quarter that ended in Mar. 2024 was €187.8 Mil.

10x Genomics's quarterly Total Liabilities increased from Sep. 2023 (€190.52 Mil) to Dec. 2023 (€205.50 Mil) but then declined from Dec. 2023 (€205.50 Mil) to Mar. 2024 (€187.75 Mil).

10x Genomics's annual Total Liabilities increased from Dec. 2021 (€178.11 Mil) to Dec. 2022 (€210.74 Mil) but then declined from Dec. 2022 (€210.74 Mil) to Dec. 2023 (€205.50 Mil).


10x Genomics Total Liabilities Historical Data

The historical data trend for 10x Genomics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Total Liabilities Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 167.26 156.40 178.11 210.74 205.50

10x Genomics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 197.68 181.22 190.52 205.50 187.75

10x Genomics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

10x Genomics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=116.608+(76.89+3.92
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+8.082+0)
=205.5

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=885.036-679.536
=205.5

10x Genomics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=100.034+(74.565+4.15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+9.004+0)
=187.8

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=849.08-661.327
=187.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics Total Liabilities Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics (STU:1KJ) Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics (STU:1KJ) Headlines

No Headlines